Novo Integrated Sciences (NVOS) has provided an update.
Novo Integrated Sciences, Inc. has actively engaged in financial maneuvers to secure and advance its business interests, including maintaining exclusivity for the Ophir Collection acquisition with repeated deposits and staying compliant with financial agreements concerning a Share Purchase Agreement and a Promissory Note. Additionally, the company is working towards monetizing a substantial Gold-Bullion backed Bond, indicating a strategic approach to leveraging assets for financial growth and stability.
Learn more about NVOS stock on TipRanks’ Stock Analysis page.
